Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
Author:
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
American Society of Nephrology (ASN)
Subject
Nephrology,General Medicine
Reference16 articles.
1. US Food and Drug Administration : Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (GS-5734™), Silver Spring, MD, US Food and Drug Administration, 2020
2. Compassionate Use of Remdesivir for Patients with Severe Covid-19
3. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
4. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
5. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Remdesivir: treatment of COVID-19 in special populations;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-05
2. Kidney Manifestations of COVID-19;Textbook of SARS-CoV-2 and COVID-19;2024
3. The Use of Remdesivir in Patients with COVID-19;Infectious Disorders - Drug Targets;2023-11
4. The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients;Hypertension Research;2023-10-23
5. Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients;Frontiers in Medicine;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3